Abstract:
The breast cancer is the most prevalent among women worldwide, represents25% of all malignancies in women with high mortality rate and changes in hematological parameters could be significant predictors toward treatments, and the course of the disease. The purpose of this study was to compare the alterations of hematological parameters in patients with breast cancer to that of healthy controls. In addition to complete blood counts, several related indices were analyzed, including hemoglobin, hematocrit, red blood cells, white blood cells, platelet indices, differential leukocyte counts, and others with automated hematological analyzer system. The results displayed notable significant differences in the parameters such as hemoglobin, hematocrit, platelet, RWD and other factors such as monocytes and basophiles indicators. Changes in the indices of platelet count and platelet volume indicated increased platelet activation, which could aid in the spread and metastasis of tumors. Increased neutrophil counts were noted, suggesting a systemic inflammatory response and compromised immunological control. Additionally, differences in hemoglobin levels indicate anemia and metabolic imbalance. Non- significant results were also observed in APTT, MCV, MCH, lymphocytes, and eosinophil’s. According to these findings, routine hematological measures may be accessible, affordable markers to supplement clinical evaluation and diagnosis in patients with breast cancer.
Page(s):
205-205
DOI:
DOI not available
Published:
Journal: 4th International Conference of Sciences “Revamped Scientific Outlook of 21st Century, 2025” , November 12,2025, Volume: 1, Issue: 1, Year: 2025
Keywords:
Hematological parameters
,
Breast Cancer
,
Tumor progression
,
predictive treatment